0001214659-25-009326.txt : 20250617 0001214659-25-009326.hdr.sgml : 20250617 20250617180006 ACCESSION NUMBER: 0001214659-25-009326 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250613 FILED AS OF DATE: 20250617 DATE AS OF CHANGE: 20250617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hare Joshua CENTRAL INDEX KEY: 0001449392 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-40060 FILM NUMBER: 251054556 MAIL ADDRESS: STREET 1: C/O 470 NAUTILUS STREET, SUITE 300 CITY: LA JOLLA STATE: CA ZIP: 92073 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Longeveron Inc. CENTRAL INDEX KEY: 0001721484 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 472174146 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1951 NW 7TH AVENUE STREET 2: SUITE 520 CITY: MIAMI STATE: FL ZIP: 33136 BUSINESS PHONE: 305-302-7158 MAIL ADDRESS: STREET 1: 1951 NW 7TH AVENUE STREET 2: SUITE 520 CITY: MIAMI STATE: FL ZIP: 33136 FORMER COMPANY: FORMER CONFORMED NAME: LONGEVERON LLC DATE OF NAME CHANGE: 20171101 4/A 1 marketforms-69947.xml PRIMARY DOCUMENT X0508 4/A 2025-06-13 2025-03-06 0001721484 Longeveron Inc. LGVN 0001449392 Hare Joshua 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 true true true false Chief Scientific Officer 0 Stock Option (right to buy) 1.33 2025-06-13 4 A false 71254 0 A 2035-03-04 Common Stock 71254 71254 D The option will 100% cliff vest on July 1, 2025. The option was administratively granted on March 4, 2025 contingent on stockholder approval at the 2025 Annual Meeting of Stockholders (the "Annual Meeting"). This Form 4/A re-reports an option disclosed in a previous Form 4, filed on March 6, 2025 to (i) correct the transaction date, which was mistakenly reported as March 4, 2025 and (ii) report that the stockholder approval contingency relating to an increase in the number of shares available for awards under the Company's 2021 Incentive Award Plan (as amended and restated to date) was satisfied upon approval of the share increase at the Annual Meeting held on June 13, 2025. /s/ Paul T. Lehr, attorney-in-fact 2025-06-17